期刊
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
卷 1876, 期 1, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.bbcan.2021.188534
关键词
Mitochondria; Metabolic reprogramming; Cancer; Intrinsic apoptosis; BCL-2 family
资金
- Shenzhen Key Laboratory of Innovative Oncotherapeutics (Shenzhen Science and Technology Innovation Commission), China [ZDSYS20200820165400003]
- Shenzhen Development and Reform Commission Subject Construction Project, China [[2017]1434]
- Guangdong Basic and Applied Basic Research Foundation, China [2020A1515111064]
- Overseas Research Cooperation Project (Tsinghua Shenzhen International Graduate School), China [HW2020008]
- TBSI Faculty Start-up Funds, China
- Shenzhen Bay Laboratory, China
Mitochondria, known as the powerhouse of cells, play essential roles in various cellular functions and are associated with human malignancies. Cancer development involves abnormalities in cellular programs, and mitochondria are recognized as key metabolic switches for normal cells to acquire malignant characteristics.
Mitochondria, well recognized as the powerhouse of cells, are maternally inherited organelles with bacterial ancestry that play essential roles in a myriad of cellular functions. It has become profoundly evident that mitochondria regulate a wide array of cellular and metabolic functions, including biosynthetic metabolism, cell signaling, redox homeostasis, and cell survival. Correspondingly, defects in normal mitochondrial functioning have been implicated in various human malignancies. Cancer development involves the activation of oncogenes, inactivation of tumor suppressor genes, and impairment of apoptotic programs in cells. Mitochondria have been recognized as the site of key metabolic switches for normal cells to acquire a malignant phenotype. This review outlines the role of mitochondria in human malignancies and highlights potential aspects of mitochondrial metabolism that could be targeted for therapeutic development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据